Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Deerland Probiotics and Enzymes | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The present study is a double-blinded randomized clinical trial with a duration of 28 days.
The present study is a double-blinded randomized clinical trial with a duration of 28 days.
80 orally and systemically healthy participant will be allocated in the test (probiotic) and the control (placebo) group at baseline.
The intervention is oral hygiene discontinuation, which will be applied at baseline and continue through day 14, followed by 14 days with regular oral care.
Clinical measurements and sampling will be performed at baseline, day 14 and day 28
Primary endpoint: Changes in microbial composition.
Secondary endpoints: Changes in clinical and immunological parameters
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Probiotic | Experimental | In this group participants will receive probiotic supplements twice a day (morning and evening) for at period of 28 days (14 days with oral hygiene discontinuation followed by 14 days with regular oral care). |
|
| Placebo | Placebo Comparator | In this group participants will receiveplacebo twice a day (morning and evening) for at period of 28 days (14 days with oral hygiene discontinuation followed by 14 days with regular oral care). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oral hygiene discontinuation | Behavioral | Oral hygiene discontinuation for 14 days followed by 14 days of regular oral care |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes in microbial composition in dental | Changes in alpha and beta diversity of microbial composition | Baseline vs. Day 14 and Day 28 |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in clinical parameters | Changes in levels of dental plaque and gingival inflammation | Baseline vs. Day 14 and Day 28 |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in salivary levels of inflammatory cytokines | Changes in mean salivary levels of selected inflammatory cytokines | Baseline vs. Day 14 and Day 28 |
Inclusion Criteria:
- age > 18 yrs.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Copenhagen, Department of Odontology | Copenhagen | 2200 | Denmark |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005891 | Gingivitis |
| ID | Term |
|---|---|
| D007239 | Infections |
| D005882 | Gingival Diseases |
| D010510 | Periodontal Diseases |
| D009059 | Mouth Diseases |
Not provided
Not provided
Double blinded randomized clinical trial with a test and placebo group
Not provided
Not provided
Computerized randomization only known to the principal investigator, who are not directly involved in data collection or data analysis
| D009057 |
| Stomatognathic Diseases |